EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunometabolomics provides a new perspective for studying systemic lupus erythematosus

Yuxian Wu, Mengpei Zhao, Na Gong, Feng Zhang, Wansheng Chen, Yaoyang Liu

International Immunopharmacology · 2023-05 · 118 · 109946

DOI: 10.1016/j.intimp.2023.109946 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023-05. Verfasst von Yuxian Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medicine, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a chronic multi-organ autoimmune disease characterized by clinical heterogeneity, unpredictable progression, and flare ups. Due to the heterogeneous nature of lupus, it has been challenging to identify sensitive and specific biomarkers for its diagnosis and monitoring. Despite the fact that the mechanism of SLE remains unknown, impressive progress has been made over the last decade towards understanding how different immune cells contribute to its pathogenesis. Research suggests that cellular metabolic programs could affect the immune response by regulating the activation, proliferation, and differentiation of innate and adaptive immune cells. Many studies have shown that the dysregulation of the immune system is associated with changes to metabolite profiles. The study of metabolite profiling may provide a means for mechanism exploration and novel biomarker discovery for disease diagnostic, classification, and monitoring. Here we review the latest advancements in understanding the role of immunometabolism in SLE, as well as the systemic metabolite profiling of this disease along with possible clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicHumansBiomarkersCell Differentiation

Stichwörter der Autor:innen

BiomarkerDiagnosisImmunometabolomicsMetabolomicsSLETreatment

Substanzen

Biomarkers

Autor:innen und Institutionen

  • College of Basic Medicine, Naval Medical University, Shanghai, China.
  • Department of Pharmacy, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Department of Pharmacy, Changzheng Hospital, Naval Medical University, Shanghai, China. Electronic address: chenwansheng@smmu.edu.cn.
  • Department of Rheumatology and Immunology, Changzheng Hospital, Naval Medical University, Shanghai, China. Electronic address: liuyaoyang000@163.com.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Wu, Y., Zhao, M., Gong, N., Zhang, F., Chen, W., & Liu, Y. (2023). Immunometabolomics provides a new perspective for studying systemic lupus erythematosus. International Immunopharmacology, 118, 109946. https://doi.org/10.1016/j.intimp.2023.109946

Vancouver

Wu Y, Zhao M, Gong N, Zhang F, Chen W, Liu Y. Immunometabolomics provides a new perspective for studying systemic lupus erythematosus. International Immunopharmacology. 2023;118:109946. doi:10.1016/j.intimp.2023.109946

BibTeX
@article{Wu2023,
  author = {Wu, Yuxian and Zhao, Mengpei and Gong, Na and Zhang, Feng and Chen, Wansheng and Liu, Yaoyang},
  title = {Immunometabolomics provides a new perspective for studying systemic lupus erythematosus},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {118},
  pages = {109946},
  doi = {10.1016/j.intimp.2023.109946}
}
Kostenlos starten →